Berit M. Pfitzner

4.6k total citations
26 papers, 620 citations indexed

About

Berit M. Pfitzner is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Berit M. Pfitzner has authored 26 papers receiving a total of 620 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 12 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Berit M. Pfitzner's work include Breast Cancer Treatment Studies (7 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Genomics and Diagnostics (6 papers). Berit M. Pfitzner is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Genomics and Diagnostics (6 papers). Berit M. Pfitzner collaborates with scholars based in Germany, United States and Switzerland. Berit M. Pfitzner's co-authors include Carsten Denkert, Manfred Dietel, Silvia Darb‐Esfahani, Oliver Fiehn, Cornelia Radke, Klaus‐Jürgen Winzer, Jan Budczies, Balázs Győrffy, Sibylle Loibl and Gϋnter von Minckwitz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Berit M. Pfitzner

25 papers receiving 612 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Berit M. Pfitzner Germany 11 262 243 236 126 72 26 620
Xianbao Zhan China 13 415 1.6× 227 0.9× 161 0.7× 160 1.3× 68 0.9× 26 671
Gabriella Gaudioso Italy 16 221 0.8× 369 1.5× 228 1.0× 156 1.2× 80 1.1× 29 778
Conor A. Bradley United States 11 290 1.1× 327 1.3× 136 0.6× 122 1.0× 96 1.3× 76 710
Ping Wen China 12 203 0.8× 296 1.2× 211 0.9× 85 0.7× 34 0.5× 33 601
Jang‐Seong Kim South Korea 14 132 0.5× 337 1.4× 179 0.8× 92 0.7× 92 1.3× 27 662
Wei‐Lun Hwang Taiwan 15 344 1.3× 503 2.1× 330 1.4× 69 0.5× 161 2.2× 29 898
Raluca Amalia Ceauşu Romania 16 251 1.0× 327 1.3× 122 0.5× 124 1.0× 158 2.2× 84 748
Abdo J. Najy United States 14 222 0.8× 367 1.5× 180 0.8× 111 0.9× 56 0.8× 23 618
Arja Jukkola‐Vuorinen Finland 15 202 0.8× 196 0.8× 145 0.6× 61 0.5× 71 1.0× 40 687
Tianhong Su China 15 171 0.7× 418 1.7× 269 1.1× 99 0.8× 112 1.6× 22 748

Countries citing papers authored by Berit M. Pfitzner

Since Specialization
Citations

This map shows the geographic impact of Berit M. Pfitzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Berit M. Pfitzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Berit M. Pfitzner more than expected).

Fields of papers citing papers by Berit M. Pfitzner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Berit M. Pfitzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Berit M. Pfitzner. The network helps show where Berit M. Pfitzner may publish in the future.

Co-authorship network of co-authors of Berit M. Pfitzner

This figure shows the co-authorship network connecting the top 25 collaborators of Berit M. Pfitzner. A scholar is included among the top collaborators of Berit M. Pfitzner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Berit M. Pfitzner. Berit M. Pfitzner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmitt, Wolfgang, Paul Jank, Inga Hoffmann, et al.. (2023). Abstract P2-03-23: Retrospective evaluation of outcomes in a real-world, prospective cohort using EndoPredict: Results from the Charité registry. Cancer Research. 83(5_Supplement). P2–3.
2.
Jank, Paul, Judith Lindner, Annika Lehmann, et al.. (2021). Comparison of risk assessment in 1652 early ER positive, HER2 negative breast cancer in a real-world data set: classical pathological parameters vs. 12-gene molecular assay (EndoPredict). Breast Cancer Research and Treatment. 191(2). 327–333. 1 indexed citations
3.
Frericks, Bernd, et al.. (2021). Two case reports: Breast schwannoma and a rare case of an axillary schwannoma imitating an axillary lymph node metastasis. SHILAP Revista de lepidopterología. 16(8). 2154–2157. 3 indexed citations
4.
Striefler, Jana K., Alexander Baur, Berit M. Pfitzner, et al.. (2020). Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience. BMC Cancer. 20(1). 68–68. 4 indexed citations
5.
Pobloth, Anne‐Marie, Hanna Schell, Anke Dienelt, et al.. (2019). Bioactive coating of zirconia toughened alumina ceramic implants improves cancellous osseointegration. Scientific Reports. 9(1). 16692–16692. 47 indexed citations
6.
Jurmeister, Philipp, Anne Schöler, Alexander Arnold, et al.. (2019). DNA methylation profiling reliably distinguishes pulmonary enteric adenocarcinoma from metastatic colorectal cancer. Modern Pathology. 32(6). 855–865. 38 indexed citations
7.
Bräutigam, Konstantin, Judith Lindner, Jan Budczies, et al.. (2019). PARP-1 expression as a prognostic factor in Desmoid-type fibromatosis. Annals of Diagnostic Pathology. 44. 151442–151442. 5 indexed citations
8.
Loibl, Sibylle, Karsten E. Weber, Jens Huober, et al.. (2018). Risk Assessment after Neoadjuvant Chemotherapy in Luminal Breast Cancer Using a Clinicomolecular Predictor. Clinical Cancer Research. 24(14). 3358–3365. 8 indexed citations
9.
Villegas, Sonia L., Silvia Darb‐Esfahani, Gϋnter von Minckwitz, et al.. (2017). Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer. Breast Cancer Research and Treatment. 168(1). 179–187. 9 indexed citations
10.
11.
Loibl, Sibylle, Silvia Darb‐Esfahani, Jens Huober, et al.. (2016). Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer. Clinical Cancer Research. 22(11). 2675–2683. 34 indexed citations
12.
Strube, Patrick, Berit M. Pfitzner, Florian Streitparth, Tony Hartwig, & Michael Putzier. (2016). In vivo effects of bupivacaine and gadobutrol on the intervertebral disc following discoblock and discography: a histological analysis. European Radiology. 27(1). 149–156. 6 indexed citations
13.
Minckwitz, Gϋnter von, Berit M. Pfitzner, Volkmar Müller, et al.. (2015). Expression of CD138 / syndecan-1 in triple-negative breast cancer – correlative study of GeparSixto. Annals of Oncology. 26. iii6–iii6. 1 indexed citations
14.
Denkert, Carsten, Berit M. Pfitzner, Barbara Ingold Heppner, & Manfred Dietel. (2015). Molekulare Pathologie beim Mammakarzinom. Der Pathologe. 36(2). 145–153. 6 indexed citations
15.
Dietel, Manfred, Korinna Jöhrens, Maximilian von Laffert, et al.. (2015). A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance. Cancer Gene Therapy. 22(9). 417–430. 102 indexed citations
16.
Schreiner, Maximilian, Wasiem Sanad, Berit M. Pfitzner, Gert Baumann, & Fabian Knebel. (2015). A Primary Intravascular Synovial Sarcoma Causing Deep-Vein Thrombosis and Pulmonary Embolism in a 20-Year-Old Woman. Current Oncology. 22(5). 387–390. 4 indexed citations
17.
Darb‐Esfahani, Silvia, Gϋnter von Minckwitz, Carsten Denkert, et al.. (2014). Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes. BMC Cancer. 14(1). 546–546. 67 indexed citations
18.
Pfitzner, Berit M., Daniel Branstetter, Sibylle Loibl, et al.. (2014). RANK expression as a prognostic and predictive marker in breast cancer. Breast Cancer Research and Treatment. 145(2). 307–315. 47 indexed citations
19.
Poremba, Christopher, Jennifer Uhlendorff, Berit M. Pfitzner, et al.. (2014). Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(4). 409–417. 12 indexed citations
20.
Budczies, Jan, Berit M. Pfitzner, Klaus‐Jürgen Winzer, et al.. (2014). Abstract 2913: Glutamate-enriched breast cancer as new entity and target for metabolic drugs. Cancer Research. 74(19_Supplement). 2913–2913. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026